Browse 1,513 myasthenia gravis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Myasthenia gravis causes muscle weakness that gets worse with use and improves with rest, often starting with a drooping eyelid or double vision. For decades treatment relied mainly on steroids and broad immune suppression, with side effects that can be hard to live with. In recent years several new targeted medicines have been approved that act directly on the antibodies behind the disease.
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
Get alerts for new trials in your area by subscribing now
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Location: Washington D.C. DC, Sarasota FL, Atlanta GA, Houston TX,
Sponsor: Avenzo Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07038343
Phase 1, Phase 2, Recruiting
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
for
Healthy Subject, Hematologic and Lymphocytic Disorder,
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 19+
Code: NCT03207854
Recruiting
Imaging of Solid Tumors Using 18F-TRX
for
Solid Tumor, Solid Carcinoma,
Location: San Francisco CA
Sponsor: Rahul Aggarwal
Sex: All
Age: 18+
Code: NCT06942104
Phase 1, Recruiting
Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors
for
Clinical Stage III Gastric Cancer AJCC v8,
Location: Houston TX
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06364410
Phase 1, Recruiting
Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
Location: New York NY, Jacksonville FL, Ann Arbor MI, Chicago IL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06401356
Phase 3, Recruiting
Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
for
Advanced Malignant Solid Neoplasm,
Location: New Haven CT, Gainesville FL, Oklahoma City OK
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05053971
Phase 1, Phase 2, Recruiting
Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors
for
Advanced Solid Tumor,
Location: Boston MA, Lebanon NH, Morristown NJ,
Sponsor: Vaxiion Therapeutics
Sex: All
Age: 18+
Code: NCT05901285
Phase 1, Recruiting
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors